Gynecologic

Gynecologic Cancer Treatment Trials

Protocol
Number

Title

ID

GOG
0274

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

Learn more.

NCT01414608
GOG
0277

A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) v. Observation for Uterus-Limited, High Grade Uterine Leiomyosarcoma

Learn more.

NCT01533207
GOG
0263

Randomized Phase III Clinical Trial of Adjuvant Radiation vs. Chemoradiation in Intermediated Risk Stage I/IIA Cervical Cancer Treated w/ Initial Radical Hysterectomy & Pelvic Lymphadenectomy

Learn more.

NCT01101451
GOG
0258

A Randomized Phase III Trial of Cisplatin & Tumor Volume Directed Irradiation followed by Carboplatin & Paclitaxel vs Carboplatin & Paclitaxel for Optimally Advanced Endometrial Carcinoma

Learn more.

NCT00942357
GOG  3004 

A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy

Learn more.

NCT01844986

Endocyte
EC-FV-06
SLHN
2013-88

A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®) in Combination Versus PLD in Participants With Platinum-Resistant Ovarian Cancer

Learn more.

NCT01170650